Denali Therapeutics Inc. (DNLI) Dividend History
Denali Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing therapeutics for neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.
Last update 03/25/2019
Dividend Yield Summary
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | |
| Dividends | - | - | - | - | - | - |
| Average Price | - | - | - | 17.97 | 18.51 | 20.87 |
| Yield | - | - | - | - | - | - |
Dividend History
No history of dividends
| Date | Amount Per Share | Note |